Skip to content

Intervention with access information via cell phone to increase the use of the HPV vaccine in people living with HIV/AIDS

Mobile device intervention to increase HPV vaccine coverage in people living with HIV/AIDS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-557mbvy
Enrollment
Unknown
Registered
2024-10-31
Start date
2022-01-06
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV infections

Interventions

This is a two-arm, double-blind, randomized controlled study. In the experimental group: individuals living with HIV/AIDS will receive information about HPV and the HPV vaccine, prepared based on the
N02.421.726.758.310.890.750

Sponsors

Centro de Pesquisas Gonçalo Moniz - FIOCRUZ/ BA
Lead Sponsor
Centro de Pesquisas Gonçalo Moniz - FIOCRUZ/ BA
Collaborator

Eligibility

Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Women and men between the ages of 18–45 years; living with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS); and who provided informed consent to participate

Exclusion criteria

Exclusion criteria: Women and men who had received any dose of human papillomavirus (HPV) vaccine

Design outcomes

Primary

MeasureTime frame
Expected outcome 1: It is expected to find a higher percentage of individuals intending to be vaccinated in the experimental group compared to the control group after the intervention, based on the finding of a difference greater than or equal to 10% in the percentage of participants who declared their intention to get vaccinated in the respective groups ;Outcome found 1: A significantly higher percentage of individuals intending to be vaccinated was observed in the experimental group (91%) compared to the control group (83%) after the intervention

Secondary

MeasureTime frame
Outcome found 2: A significantly higher percentage of individuals starting vaccination (receiving at least one dose of vaccine) was observed in the experimental group (28%) compared to the control group (16%) after the intervention;Expected outcome 2: It is expected to find a higher percentage of initiation of vaccination (receipt of at least one dose of vaccine) in individuals in the experimental group compared to the control group after the intervention, based on the finding of a statistically significant difference in the percentage of participants who started vaccination in their respective groups

Countries

Brazil

Contacts

Public ContactKaliane Brito

Instituto Gonçalo Moniz

kaliane.caldas@fiocruz.br+55-71-3176-2343

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 5, 2026